NEWS

We, the undersigned CEOs of global biotechnology companies and associations have a socialresponsibility to work with other stakeholders – healthcare providers, governments, multilateralorganizations, and non-governmental donor organizations – to ensure that COVID vaccines andtreatments get to the patients in the world who most need them. We are working hard to fulfill thisresponsibility.• Our sector must…

Researchers will evaluate antibody responses in vaccinated participants and their infants. A new observational study has begun to evaluate the immune responses generated by COVID-19 vaccines administered to pregnant or postpartum people. Researchers will measure the development and durability of antibodies against SARS-CoV-2, the virus that causes COVID-19, in people vaccinated during pregnancy or the…

ATLANTA, June 11, 2021 /PRNewswire/ — Mikart, LLC a comprehensive contract development and manufacturing organization recently acquired a state-of-the-art Korsch XM12 to meet their Pharmaceutical client demands for complex formulation development and production of oral solid dose products. Mikart CEO Michael Kallelis stated, “Mikart has a 45-year history as a CDMO for solid oral and liquid oral formulation development…

Vaccine maker Novavax said Monday its COVID-19 shot was highly effective against the disease and also protected against variants in a large study in the U.S. and Mexico, potentially offering the world yet another weapon against the virus at a time when developing countries are desperate for doses. The two-shot vaccine was about 90% effective…

U.S. government to purchase at not-for-profit price 200 million doses in 2021 and 300 million in the first half of 2022 Doses to be donated to approximately 100 low- and lower middle-income countries including those in the African Union via the COVAX Facility Effort is part of the companies’ recent pledge of two billion doses…

The discovery, made possible by a partnership between a research group and a startup in São Paulo state (Brazil), could lead to novel treatments for intracranial hypertension and its complications, such as stroke Brazilian researchers have simultaneously demonstrated the mechanism linking high blood pressure to elevated intracranial pressure, validated a non-invasive intracranial pressure monitoring method,…